GlassScriptPhysician profile
Ajay M Narwani
NPI 1750439824
$7,876.86
in general payments reported to CMS, 2019-2025
41 companies · $1,032 in 2025
The $1,032 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,662 · 2020: $969 · 2021: $523 · 2022: $842 · 2023: $1,151 · 2024: $1,697 · 2025: $1,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,859 · Education: $21.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,858.92 |
| Education | $21.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,281.75 | 2019-2025 | Proclaim, Prodigy, Swift-Lock |
| Boston Scientific Corporation | $1,505.36 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $517.82 | 2019-2025 | Relistor |
| Medtronic USA, INC. | $279.20 | 2019-2020 | |
| Nevro Corp. | $247.97 | 2019-2024 | Senza |
| Nalu Medical, INC. | $232.81 | 2021-2024 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $196.30 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $157.68 | 2019-2025 | Xtampza, Belbuca |
| Scilex Pharmaceuticals INC. | $133.49 | 2019-2024 | Ztlido |
| Protega Pharmaceutials INC | $132.62 | 2024-2025 | Roxybond |
| Hikma Pharmaceuticals USA | $129.60 | 2021-2022 | |
| Daiichi Sankyo INC. | $111.99 | 2019 | |
| Amgen INC. | $95.89 | 2019-2021 | |
| Bioventus LLC | $70.25 | 2019-2023 | Gelsyn-3 |
| Astrazeneca Pharmaceuticals LP | $62.28 | 2019-2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Narwani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.